Assembly Biosciences, Inc. (ASMB) vs NeuroPace, Inc. (NPCE)
A side-by-side comparison of Assembly Biosciences, Inc. and NeuroPace, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$21.98HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
NPCE
NeuroPace, Inc.
$13.04HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — ASMB vs NPCE
growth of $100 · dividends reinvested · last 5yASMB -53.7% (-14.3%/yr)NPCE -47.0% (-11.9%/yr)NPCE compounded faster over this window
ASMB NPCE
ASMB vs NPCE: by the numbers
- •NPCE is the larger company ($445M vs $435M market cap).
- •Both run net losses; ASMB's is the smaller (-0.06% vs -19.34% net margin).
- •NPCE grew revenue faster over the past five years (15.85% vs -1.78% CAGR).
Metrics side by side
Valuation
| Metric | ASMB | NPCE |
|---|---|---|
| P/E ratio | 39.95 | N/A |
| P/S ratio | 5.82 | 4.50 |
| P/B ratio | 1.42 | 37.41 |
Profitability
| Metric | ASMB | NPCE |
|---|---|---|
| Gross margin | 99.82% | 79.63% |
| Operating margin | -11.75% | -15.26% |
| Net margin | -0.06% | -19.34% |
| ROE | -0.01% | -160.85% |
| ROIC | -2.86% | -18.95% |
Growth (annualized)
| Metric | ASMB | NPCE |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | 15.85% |
| Total return CAGR (5Y) | -10.66% | -4.94% |
Frequently asked
- Which has grown faster, ASMB or NPCE?
- Over the past five years, NPCE grew revenue faster — ASMB at a -1.78% CAGR versus NPCE at 15.85%.
- How have ASMB and NPCE total returns compared?
- Over the past 5 years, ASMB delivered -10.66% and NPCE delivered -4.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Assembly Biosciences P/E ratioAssembly Biosciences ROENeuroPace ROEAssembly Biosciences operating marginNeuroPace operating marginAssembly Biosciences revenue growthNeuroPace revenue growthAssembly Biosciences free cash flowNeuroPace free cash flow
Assembly Biosciences & NeuroPace appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.